Sentence examples for microbiological failure and from inspiring English sources

Primary outcomes studied were clinical failure, microbiological failure, and relapse.

No asymmetry was detected for clinical failure, but some asymmetry was detected for microbiological failure and relapse.

However, some asymmetry observed for microbiological failure and relapse for trials involving chloramphenicol suggests the possibility of publication bias or failure to publish smaller studies showing non-significant results.

Funnel plots The number of trials (4 to 7) in included funnel plots for outcomes clinical failure, microbiological failure and relapse was well below the recommended number of trials (10) for meaningful interpretation.

The age, APACHE II score, type of infection, length of ICU stay, length of mechanical ventilation, mortality, clinical and microbiological failure and length of vancomycin therapy and total dose of vancomycin were assessed.

63 64 65 Final follow-up of confirmed cases was adequate in 13. 40 65666869 70 71 72 73 76 78 73 76 78 Definitions and time points of measurements for outcomes such as clinical and microbiological failure showed considerable variations.

Failure was a composite of death, persistent sepsis or organ failure, haemodynamic instability and microbiological failure.

Clinically evaluated failure of therapy in the continuous versus intermittent groups was in 12 (36%) patients versus eight (25%) patients, and microbiological failure in seven (21%) patients versus eight (25%) patients.

He was then empirically given 500 mg of azithromycin, but experienced clinical and microbiological failure of azithromycin treatment for enteric fever due to Salmonella Paratyphi A. However, the minimum inhibitory concentration (MIC) of azithromycin was not elevated (8 mg/L).

The funnel plots for most outcomes in the comparison of antimicrobial versus placebo/no treatment did not show a small study effect; only in the clinical and microbiological failure analyses did small studies tend to show a larger effect, but these analyses included only a small proportion of existing studies.

With ofloxacin there was a significant increase in clinical failure (2.67 (1.16 to 6.11), n=125), no significant differences in microbiological failure (0.98 (0.13 to 7.21), n=125), and no relapses at one month follow-up (<90% participants followed).